These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 5519106)

  • 41. [Treatment of typhoid with levomycetin combined with vaccination (intradermal and by electrophoresis)].
    Alisov PA; Kazantsev AP
    Sov Med; 1965 Sep; 28(9):66-71. PubMed ID: 5871702
    [No Abstract]   [Full Text] [Related]  

  • 42. [The effectiveness of vaccinating 3 to 7 year old children against typhoid fever with a purified preparation of S. typhi Vi-antigen (based on data from a controlled epidemiologic trial)].
    Shatrov II; Pokrovskaia MP; Braĭnina RA; Chernysheva NA; Spotarenko SS; Sraskina NA; Allakhverdov EM; Gavrilova AS
    Zh Mikrobiol Epidemiol Immunobiol; 1966 May; 43(5):39-43. PubMed ID: 6003713
    [No Abstract]   [Full Text] [Related]  

  • 43. [INCIDENCE AND DIAGNOSTIC SIGNIFICANCE OF TYPHOID VI-PHAGES IN MAN].
    HUDEMANN H
    Pathol Microbiol (Basel); 1965; 28():181-4. PubMed ID: 14299863
    [No Abstract]   [Full Text] [Related]  

  • 44. [Clinico-immunological characteristics of the results of treatment of patients with typhoid by a complex method using VI-antigen, monovaccine, and levomycetin].
    Bunin KV; Deriagin IuP
    Sov Med; 1974 May; 37(5):8-12. PubMed ID: 4832529
    [No Abstract]   [Full Text] [Related]  

  • 45. [Typhoid epidemic at Pozzallo, with special reference to the fecal elimination of Salmonella typhi in typhoid subjects treated with chloromycetin].
    CEFALU M; GIUSTOLISI G
    Ann Sanita Pubblica; 1950; 11(1):121-31. PubMed ID: 15419570
    [No Abstract]   [Full Text] [Related]  

  • 46. Study of induced typhoid fever in man. I. Evaluation of vaccine effectiveness.
    Hornick RB; Woodward TE; McCrumb FR; Snyder MJ; Dawkins AT; Bulkeley JT; De la Macorra F; Corozza FA
    Trans Assoc Am Physicians; 1966; 79():361-7. PubMed ID: 5929469
    [No Abstract]   [Full Text] [Related]  

  • 47. [Bacteriological-serological studies on the chloramphenicol sensitivity of the typhoid and paratyphoid bacteria].
    SAGEBIEL W
    Arch Hyg Bakteriol; 1951; 135(3):222-31. PubMed ID: 13041212
    [No Abstract]   [Full Text] [Related]  

  • 48. [Combined treatment of patients with typhoid with levomycetin, apilar, typhoid monovaccine and total ultraviolet irradiation].
    Normanskiĭ ES; Ivanovskaia KN; Koshkin AI; Podlevskiĭ AF
    Antibiotiki; 1966 May; 11(5):471-5. PubMed ID: 5993094
    [No Abstract]   [Full Text] [Related]  

  • 49. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
    Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
    Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
    [TBL] [Abstract][Full Text] [Related]  

  • 50. AMPICILLIN IN TREATMENT OF SALMONELLA TYPHI CARRIERS.
    WHITBY JM
    Lancet; 1964 Jul; 2(7350):71-2. PubMed ID: 14158684
    [No Abstract]   [Full Text] [Related]  

  • 51. [Immunological characteristics of the blood in exposure to typhoid fever antigens].
    Andrievskaia RA; Dadalova AI; Kraeva VN; Pakhomova LV
    Voen Med Zh; 1978; (5):49-50. PubMed ID: 664388
    [No Abstract]   [Full Text] [Related]  

  • 52. The unmasking of typhoid fever.
    Woodward TE
    S Afr Med J; 1970 Jan; 44(5):99-106. PubMed ID: 5415784
    [No Abstract]   [Full Text] [Related]  

  • 53. [Mechanisms of protection in the pathogenesis of the typhoid bacterial carrier state].
    Obgol'ts AA
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Aug; (8):98-103. PubMed ID: 6195845
    [No Abstract]   [Full Text] [Related]  

  • 54. COMPARATIVE EXAMINATION OF CHRONIC TYPHOID CARRIERS WITH IMMUNOFLUORESCENT AND CULTURAL METHODS.
    GECK P; SZANTO R
    Acta Microbiol Acad Sci Hung; 1964-1965; 11():211-4. PubMed ID: 14267552
    [No Abstract]   [Full Text] [Related]  

  • 55. Review of current typhoid fever vaccines, cross-protection against paratyphoid fever, and the European guidelines.
    Zuckerman JN; Hatz C; Kantele A
    Expert Rev Vaccines; 2017 Oct; 16(10):1029-1043. PubMed ID: 28856924
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [In vitro susceptibility of typhoid, paratyphoid and dysentery bacilli to aureomycin and chloramphenicol].
    ALIN K; WALLMARK G
    Nord Med; 1950 Apr; 43(16):663-4. PubMed ID: 14796936
    [No Abstract]   [Full Text] [Related]  

  • 57. [Is the Widal reaction for typhoid and paratyphoid influenced by the oral intake of larger amounts of killed Salmonella?].
    Finger H; Seeliger H; Schmidt H
    Dtsch Med Wochenschr; 1967 May; 92(19):887-90. PubMed ID: 4960680
    [No Abstract]   [Full Text] [Related]  

  • 58. Preparation of typhoid somatic-antigen vaccine. III. The rabbit intracutaneous challenge with Salmonella typhi in mucin.
    DIENA BB; WALLACE R; GREENBERG L
    Can J Microbiol; 1962 Feb; 8():35-41. PubMed ID: 13886263
    [No Abstract]   [Full Text] [Related]  

  • 59. Immunological control of typhoid fever.
    Hornick RB
    J Egypt Public Health Assoc; 1970; 45(1):236-46. PubMed ID: 5484828
    [No Abstract]   [Full Text] [Related]  

  • 60. A CHALLENGE TO THE VALIDITY OF THE VI TEST FOR THE DETECTION OF CHRONIC TYPHOID CARRIERS.
    BOKKENHEUSER V; SMIT P; RICHARDSON N
    Am J Public Health Nations Health; 1964 Sep; 54(9):1507-13. PubMed ID: 14215893
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.